Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche's new PD-L1 bladder cancer drug could be on the market by September
Fierce Biotech
Tue, 03/15/16 - 10:35 pm
Tags:
Roche, PD-L1, bladder cancer, atezolizumab
India reclears Roche's Avastin for off-label eye sales
Fierce Pharma Marketing
Mon, 03/14/16 - 05:53 pm
Tags:
India, Roche, Avastin, off-label
New rivals, formulary squeeze pose a double threat to Biogen MS sales
Fierce Pharma
Mon, 03/7/16 - 10:04 pm
Tags:
Biogen, formulary, MS, multiple sclerosis, Roche, ocrelizumab, Tecfidera
Roche looks beyond Tamiflu, striking deal for Shionogi's flu fighter
Fierce Pharma
Sat, 03/5/16 - 09:45 am
Tags:
Roche, Tamiflu, Shionogi, Flu
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Tags:
Opdivo, immuno-oncology, Bristol-Myers Squibb, Eli Lilly, Merck, Roche, AstraZeneca, Novartis
Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs
Fierce Biotech
Mon, 02/29/16 - 10:30 am
Tags:
Roche, Genentech, asthma, clinical trials, lebrikizumab
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial
Bloomberg
Sun, 02/28/16 - 10:52 am
Tags:
Regeneron, dry eye disease, Roche, Lucentis, Eylea
Roche Holding Moves Ahead in Cancer Drugs Race; Wins Expanded FDA Approval for Gazyva
Bidness, ETC
Sat, 02/27/16 - 09:23 am
Tags:
Roche, FDA, Gazyva, follicular lymphoma
Rivals chase Bristol-Myers in cancer immunotherapy drug race
Yahoo/Reuters
Fri, 02/26/16 - 11:03 am
Tags:
Bristol-Myers Squibb, cancer immunotherapy, Roche, AstraZeneca, Merck, Opdivo
New drug for severe form of MS generates glimmer of hope — and tempered expectations
Stat
Fri, 02/19/16 - 10:07 am
Tags:
MS, multiple sclerosis, Roche, ocrelizumab
Are the big M&A players in biopharma waiting out the bear market?
Fierce Biotech
Tue, 02/9/16 - 02:15 pm
Tags:
M&A, Roche, Eli Lilly, Gilead Sciences, Sanofi, Biogen
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Tags:
Intercept Pharmaceuticals, Gilead Sciences, Roche, AbbVie, Merck, obeticholic acid, emtricitabine
Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Fierce Pharma
Mon, 02/1/16 - 01:49 pm
Tags:
Roche, drug pricing, Rituxan, Avastin, Herceptin
Roche looks ahead to immuno-oncology, MS to back up big-selling cancer meds
Fierce Pharma
Fri, 01/29/16 - 08:23 pm
Tags:
Roche, MS, multiple sclerosis, immuno-oncology
Roche Falls After Full-Year Profit Misses Analyst Estimates
Bloomberg
Thu, 01/28/16 - 08:44 am
Tags:
Roche, earnings
Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool
Yahoo
Wed, 01/27/16 - 10:56 am
Tags:
Eli Lilly, Roche, diagnostics, Alzheimer's disease
Dozens of drug makers agree on effort to combat antibiotic resistance
Stat
Wed, 01/20/16 - 09:36 pm
Tags:
antibiotic resistance, Merck, Pfizer, Sanofi, JNJ, Roche, Novartis, AstraZeneca
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
BioPharma Dive
Wed, 01/20/16 - 09:35 pm
Tags:
Avastin, India, off-label, Roche, wet age-related macular degeneration
Hemophilia marketing tactics raise questions as market heats up
Fierce Pharma
Thu, 01/14/16 - 08:47 pm
Tags:
hemophilia, drug marketing, Biogen, CSL, Bayer, Roche
Roche and AbbVie line up for quick approval for cancer drug venetoclax
Fierce Biotech
Tue, 01/12/16 - 09:19 pm
Tags:
AbbVie, Roche, venetoclax, chronic lymphocytic leukemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.